Eric Rose

Rose is an American cardiothoracic surgeon, scientist, entrepreneur and professor and Chairman of the Department of Population Health Science & Policy, and Associate Director for Clinical Outcomes at Mount Sinai Heart.

Rose has co-founded several biotechnology companies and has been involved in developing anti-virals to smallpox, new medical technologies and new approaches to Alzheimer's disease and bioterrorism.

[11] Magnifying glasses helped Rose visualise James's small heart during the surgery and afterwards, rejection was prevented by tailoring the dose of cyclosporine.

[14] The previous day, a 28-year-old man from The Bronx had died of severe brain injury at Montefiore Medical Center and his family had consented to donate his kidneys, liver, pancreas and heart.

Computer software used by the New York Regional Transplant Programme matched blood, tissue type and dimensions of the heart of this donor with that of John's.

[15] On the morning of the operation, Rose, with Mehmet Oz, MD who was his deputy in the NYP/Columbia Department of Cardiothoracic surgery at the time, took four hours to complete the procedure and by midday the surrounding publicity was immense.

[15] The operation was successful and over the coming days, Frank managed to watch his brother’s baseball team beat the Atlanta Braves to win the Series.

[14] During the 1990s, LVADs were used successfully as a bridge-to-transplantation device, that is, to fill the time before a suitable donor could be found, and medical treatment options were limited.

Its safety and life expectancy were unknown, and it was unclear as to whether they would provide better outcomes than conventional treatment with medication in people with severe heart failure.

[16][18][19] Rose co-founded several biotechnology companies including Nephros, which is concerned with heart and kidney related medical devices, and between 1997 and 2009, has served at various points, as its chairman, president, chief executive and director.

[3] Rose has authored and co-authored more than 300 peer-reviewed articles on subjects including cardiovascular surgery, ventricular assist devices, and cardiac transplantation.